These findings suggest that metformin can be a promising anti-fibrotic modality of treatment for IPF affected by TGF-β.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: